Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States. Issue 3 (24th January 2022)

• Record Type: Journal Article
• Authors: Hsieh, Yuli Lily; Rak, Summer; SteelFisher, Gillian K; Bauhoff, Sebastian
• Is Part Of: Vaccine. Volume 40:Issue 3(2022)
• Page Start: 424
• Page End: 427
• Publication Date: 2022-01-24
• Subjects: Vaccine hesitancy -- COVID-19 -- Vaccine safety -- USA; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2021.11.085
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended "a pause in the use of this vaccine out of an abundance of caution." We examined whether public attitudes toward COVID-19 vaccination shifted after this recommended suspension using an interrupted time series with data from the Census Bureau's Household Pulse Survey, which was fielded bi-weekly between January 6 and April 26, 2021. We found no significant changes in trends of the proportion of the U.S. adult population hesitant about getting a COVID-19 vaccine, but a significant increase in concerns about safety and efficacy of COVID-19 vaccines among the already hesitant population.